Listed on GrantGunner. Last checked 4 Oct 2026.
About this grant
The Beijing Institute of Stem Cells and Regenerative Medicine has launched a clinical translational application research program, funding proof-of-concept, preclinical, and clinical studies in areas such as stem cell regenerative medicine, organoid technology, and new drug development. It implements a phased, milestone-based rolling funding mechanism, with a maximum grant of 10 million yuan per project.
More grants from Beijing Institute of Stem Cell and Regenerative Medicine